4//SEC Filing
Chambers Michael Andrew 4
Accession 0001209191-23-045766
CIK 0000873303other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 8:00 AM ET
Size
8.2 KB
Accession
0001209191-23-045766
Insider Transaction Report
Form 4
Chambers Michael Andrew
Director
Transactions
- Purchase
Common Stock
2023-08-14$109.19/sh+5,947$649,353→ 242,964 total(indirect: By Trust) - Purchase
Common Stock
2023-08-14$109.89/sh+4,032$443,076→ 246,996 total(indirect: By Trust)
Holdings
- 6,431
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $108.54 to $109.54, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $109.67 to $110, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001932527
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 8:00 AM ET
- Size
- 8.2 KB